Montreal-based technology innovator HPQ Silicon Inc. has successfully closed a significant private funding round, securing over one million dollars to fuel the advancement of its core technology platforms. The company announced the completion of a non-brokered private placement on December 15, 2025.
Details of the Private Placement
HPQ Silicon issued 6,170,442 common shares at a price of $0.1625 per share, generating gross proceeds of $1,002,696.83. All securities issued as part of this financing are subject to a standard four-month-and-one-day statutory hold period under Canadian securities laws. The transaction remains pending final acceptance by the TSX Venture Exchange, where HPQ trades under the symbol HPQ.
In connection with the placement, the company will pay commissions by issuing 333,303 warrants to CI Investment Services Inc. Each warrant grants the right to purchase one common share at $0.18 for a period of 48 months from the closing date.
Strategic Use of Proceeds for Core Technologies
The net proceeds from this financing are earmarked for general working capital and, more strategically, to accelerate the commercialization of HPQ's three flagship technology pillars.
The Fumed Silica Reactor (FSR) initiative will focus on scaling up for commercial opportunities and establishing clear revenue generation pathways.
For its HPQ ENDURA+™ battery technology, funds will support the commercialization of battery cells and advance a silicon-based anode material program backed by Natural Resources Canada (NRCan).
The company will also continue development and commercialization efforts for its METAGENE™ autonomous green hydrogen production platform.
Insider Participation and Governance
The private placement saw participation from company leadership, underscoring internal confidence. Bernard Tourillon, Chairman, President, CEO, and a Director of HPQ, subscribed for 615,384 shares, representing an investment of $99,999.90.
Following this transaction, Mr. Tourillon's beneficial ownership stands at approximately 5.29% of the company's issued and outstanding shares. This insider participation was structured as a related-party transaction under applicable securities rules. The company relied on exemptions from formal valuation and minority approval, as the transaction's value did not exceed 25% of the market capitalization. The placement, including insider involvement, received approval from HPQ's Board of Directors.
This injection of capital positions HPQ Silicon to make significant strides in bringing its advanced material and clean technology solutions from development towards market-ready applications.
